beat365Õý°æΨһ¹ÙÍø

¿ÆÑÐЧÀÍ

RESEARCH SERVICES
¿ÆÑÐЧÀÍ
Éñ¾­µÝÖÊ
Éñ¾­µÝÖʲúÆ·¼ò½é

Éñ¾­µÝÖÊÊÇÖ¸Éñ¾­Ä©ÉÒÊͷŵÄÌØÊ⻯ѧÎïÖÊ £¬ËüÄÜ×÷ÓÃÓÚÖ§ÅäµÄÉñ¾­Ôª»òЧӦϸ°ûĤÉϵÄÊÜÌå £¬´Ó¶øÍê³ÉÐÅϢת´ï¹¦Ð§¡£Éñ¾­µÝÖʵÄÕý³£ÊͷŹØÓÚά³Ö»úÌåÕý³£µÄÐÄÀí¹¦Ð§Ê©Õ¹×ÅÖ÷Òª×÷Óà £¬Í¬Ê± £¬Éñ¾­µÝÖʵÄÊÍ·ÅÓëµ÷Àí·ºÆðÒ쳣ʱҲÓëһϵÁеIJ¡ÀíÀú³ÌÏà¹Ø £¬ÈçÒÖÓôÖ¢(Depression)¡¢³Éñ«(Addiction)¡¢ÅÁ½ðÉ­ÊÏÖ¢(Parkinson's disease £¬PD)ºÍ°¢¶û×Ⱥ£Ä¬Ö¢(Alzheimer's disease £¬AD)µÈ ¡£ Òò´Ë £¬ÔÚ·Ö×Ó¡¢Ï¸°û¡¢»·Â·µÈ²ãÃæ׼ȷµØÆÊÎö¼ì²âÉñ¾­µÝÖÊÊÇÔõÑù¼ÓÈë²¢µ÷ÀíÉÏÊöÐÄÀíºÍ²¡ÀíÀú³Ì £¬Äܹ»¸üÉîÈëµØÏàʶ¼²²¡µÄ·¢²¡»úÖÆ £¬²¢ÎªÁÙ´²Ò©ÎïµÄ¿ª·¢µÓÚ¨»ù´¡¡£
Éñ¾­µÝÖʼ°Æä´úл²úÆ·ÆÕ±éÂþÑÜÓÚÖÐÊàºÍÍâÖÜÉñ¾­ÏµÍ³ £¬ÔÚά³Ö¸÷ÏîÉúÔËÆø¶¯ÖÐÆðןÜÊÇÖ÷ÒªµÄ×÷ÓÃÒѾ­Ö¤Êµ¡£Éñ¾­µÝÖʵÄʧµ÷»òÔÓÂҺͶàÖÖÉñ¾­¼²²¡Ç×½üÏà¹Ø £¬ÈçÅÁ½ðÉ­¼²²¡(Parkinson's disease, PD)¡¢½¹ÂÇ¡¢ ¾«ÉñÆÆËé¡¢ÒÖÓôºÍ°¢¶û×Ⱥ£Ä¬²¡(Alzheimer's disease, AD)µÈ¡£Òò´Ë £¬¸ßͨÁ¿¼ì²â¼°ÆÊÎöÉñ¾­µÝÖÊÀàÎïÖÊ £¬¶ÔÕ¹ÏÖÉñ¾­ÏµÍ³À༲²¡µÄ·¢²¡»úÖƺÍÕï¶ÏÖÎÁÆÓÐÖ÷ÒªµÄÑо¿ÒâÒå¡£

Éñ¾­µÝÖÊ

Éñ¾­µÝÖÊÀàÎïÖʼì²âÁбí
×¢£º¹²¿É¼ì²â42ÖÖÖÐÐÄ̼´úлÎïÖÊ

1¶Ô1×Éѯ

ʸÁ¿ÖÇÄܹ¤¾ßÊÖÒÕÓÅÊÆ

¸ßͨÁ¿£º½ÓÄɸßËÙÊÕÂÞËÙÂÊÖÊÆ×ƽ̨ £¬Í¬Î»ËØÄÚ±êÑéÖ¤ £¬¿Éͬʱ¾ø¶Ô¶¨Á¿¶àÖÖÉñ¾­µÝÖÊÀàÎïÖÊ

רҵЧÀÍ£ºÍêÉƵÄÊÛºóЧÀÍ £¬Ö§³Öµ½Êý¾Ý½ÒÏþ

Éñ¾­µÝÖÊ(ͼ3)ÊÖÒÕõ辶

µ¨Ö­ËáÊÖÒÕõ辶

Éñ¾­µÝÖÊ(ͼ5)ÊÖÒÕ²ÎÊý

Ñù±¾ÒªÇó
Ö²Îï×éÖ¯£º200 mg/sample
¶¯Îï×éÖ¯Ñù±¾£º200 mg/sample
ѪÇ塢Ѫ½¬£º200 ¦ÌL/sample
ϸ°û£º1X10cells/sample
·à±ã£º200 mg/sample

Öü´æºÍÔËÊä
Òºµª»ò-80¡ãCÉúÑÄ £»×ãÁ¿¸É±ùÔËÊä £¬×èÖ¹Öظ´¶³ÈÚ

¼ì²âƽ̨
Qtrap 6500+, Sciex

ͨÀýÖÜÆÚ
ʵÑé¼ì²â£º30¸ö×ÔÈ»ÈÕ£¨´ÓÊÕµ½¿Í»§Ô¤¸¶¿î²¢ÊÕµ½ÑùÆ·Ö®ÈÕÆð£©
Êý¾ÝÆÊÎö£º5¸ö×ÔÈ»ÈÕ

icon-27.pngÓ¦ÓÃÆ«Ïò
  • beat365Õý°æΨһ¹ÙÍø - bet36(Öйú)¹Ù·½ÍøÕ¾
    ×é֯ϸ°ûµÈÑù±¾ÖÐÉñ¾­µÝÖÊÀàÎïÖÊÅжÏ
  • icon
    Éñ¾­ÏµÍ³À༲²¡µÄ·¢²¡»úÖƺÍÔçÆÚÕï¶Ï
  • icon
    ËÇÁÏÌí¼Ó¼Á
  • beat365Õý°æΨһ¹ÙÍø - bet36(Öйú)¹Ù·½ÍøÕ¾
    ÎÛȾÎïÉñ¾­¶¾ÐÔµÄÉúÎï±ê¼ÇÎï
icon-28°¸ÀýÆÊÎö

»ùÓÚ¶àÖÖѪ½¬Éñ¾­µÝÖÊת±äµÄÒÖÓôÖ¢Õï¶Ï£ºÒ»Ïî°ÐÏò´úл×éѧÑо¿

Ñо¿¹¤¾ß£º                ÒÖÓôÖ¢»¼Õß

ÆÚ¿¯£º                      Translational Psychiatry

Ó°ÏìÒò×Ó£º                6.22

ʱ¼ä£º                      2018Äê

Ñо¿Åä¾°
ÖضÈÒÖÓôÖ¢(Major Depressive Disorder, MDD)ÊÇÒ»ÖÖʹÈËÐéÈõµÄ¾«Éñ¼²²¡¡£ÖÐÊàºÍÍâÖÜÉñ¾­µÝÖʵÄÔÓÂÒÊÇMDDµÄÒ»¸öÌØÕ÷ £¬MDD»¼ÕßµÄÐí¶àÉñ¾­µÝÖÊÀàÎïÖʶ¼Êܵ½×ÌÈÅ¡£ÏÖÔÚ £¬MDDµÄÕï¶ÏÖ÷ÒªÒÀÀµ¾«Éñ¿ÆÒ½Éú¶Ô֢״ȺµÄÖ÷¹Ûʶ±ð £¬ÎóÕïÂʽϸß £¬ÆäÖÐÓÉÓÚÁÙ´²Ö¢×´ÏàËÆ £¬Ë«ÏàÇéÐ÷ÕÏ°­(Bipolar Disorder, BD)²¡Àý¾Í³£±»ÎóÕïΪMDD¡£²»µ½Ò»°ëµÄMDD»¼Õߣ¨ÔÚÐí¶à¹ú¼Ò £¬²»µ½10%£©½ÓÊÜÁËÓÐÓõÄÖÎÁÆ¡£Òò´Ë £¬MDDµÄ¿Í¹ÛÕï¶ÏÒªÁ콫¾ßÓÐÏ൱´óµÄÁÙ´²¼ÛÖµ¡£È»¶ø £¬ÏÖÔÚ»¹Ã»ÓÐÕë¶ÔÕâÖÖ¼²²¡µÄ¿Í¹ÛʵÑéÊÒÕï¶Ï²âÊÔ¡£

Ñо¿Ð§¹û
ʹÓÃÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓÃ(Gas Chromatography-Mass Spectrometry, GC-MS)ºÍÒºÏàÉ«Æ×-´®ÁªÖÊÆ×(LC-MS/MS)¶Ô19ÖÖÉñ¾­µÝÖʺÍÏà¹Ø´úлÎï¾ÙÐж¨Á¿ÆÊÎö £¬·¢Ã÷GABAͨ·ºÍ¶ù²è·Ó°·Í¨Â·±È5-ôÇÉ«°·Í¨Â·¶ÔMDDµÄÕï¶ÏЧ¹û¸üºÃ¡£ÇÒ·¢Ã÷ÁËËÄÖÖѪ½¬´úлÎDOPN¡¢GABA¡¢TyraºÍKyn£©¿ÉÒÔÓÐÓÃÇø·ÖMDD»¼ÕߺͿµ½¡±ÈÕÕÕß £¬²¢ÇÒ¿ÉÒÔÓÐÓÃÇø·ÖMDDÊÜÊÔÕßÓëË«ÏàÇéÐ÷ÕÏ°­(Bipolar Disorder, BD)ÊÜÊÔÕß¡£ÕâЩЧ¹ûÅúעʹÓÃGC-MSÍŽáLC-MS/MS°ÐÏò´úл×éѧҪÁì £¬È·¶¨µÄDZÔÚµÄѪ½¬Õï¶Ï´úлÎï×éÄܹ»¸ß¾«¶ÈµØ½«ÒÖÓôÖ¢»¼ÕßÓ뿵½¡±ÈÕÕ×éºÍBDÊÜÊÔÕßÇøÍÑÀëÀ´¡£ÕâЩ·¢Ã÷ÓÐÖúÓÚÕ¹ÏÖMDDµÄ·Ö×Ó·¢²¡»úÖÆ £¬Îª¼²²¡µÄÕï¶ÏºÍÔ¤ºó¼ì²âµÓÚ¨»ù´¡¡£

Ñо¿Ë¼Ð÷

Ñо¿Ë¼Ð÷

Ч¹ûչʾ
ÆÀ¹ÀÊ״α¬·¢Ê±·þÓÿ¹ÒÖÓôÒ©ÎïµÄ³õÖÎMDD»¼ÕßÓ뿵½¡±ÈÕÕ¸öÌåµÄѪ½¬Ñù±¾ £¬»ñµÃÁ½×éÖвî±ðÏÔÖøµÄ´úлÎͼ1£©¡£Ê¹ÓÃÏà¹ØÐÔÆÊÎö£¨Í¼2A£©¶Ô²î±ð´úлÎï¾ÙÐй¦Ð§·Ö×é²¢¾ÙÐÐROCÆÊÎö£¨Í¼2B-D£© £¬·¢Ã÷GABAͨ·ºÍ¶ù²è·Ó°·Í¨Â·±È5-ôÇÉ«°·Í¨Â·¶ÔMDDµÄÕï¶ÏЧ¹û¸üºÃ¡£Ê¹ÓöþÔªÂß¼­»Ø¹éÆÊÎö²¢¾ÙÐÐROCÆÊÎö·¢Ã÷ÓÉDOPN¡¢GABA¡¢TyraºÍKyn´úлÎï×é³ÉµÄÉúÎï±ê¼ÇÎï×é¿ÉÒÔÌṩMDD»¼ÕߺͿµ½¡±ÈÕÕ×éÖ®¼ä×îÏÔÖøµÄÎó²î(ͼ3A)¡£Ê¹ÓÃÒÑÅжϵĴúлÎï¹¹½¨PLS-DA £¬»ñµÃÓëROCÆÊÎöÒ»ÖµÄЧ¹û£¨Í¼3B£©¡£¶ÔËÄÖÖѪ½¬´úлÎDOPN¡¢GABA¡¢TyraºÍKyn£©µÄŨ¶È¾ÙÐÐÁË×ÔÁ¦Á¿»¯ÇÒ¾ÙÐÐROCÆÊÎö£¨Í¼3C¡¢D£© £¬Ð§¹ûÅú×¢ÕâЩѪ½¬´úлÎï¿ÉÒÔÓÐÓÃÇø·ÖMDDÊÜÊÔÕߺͿµ½¡±ÈÕÕÕßÇÒ¿ÉÒÔÓÐÓÃÇø·ÖMDDÊÜÊÔÕßÓëBDÊÜÊÔÕß¡£

ͼ

ͼ2

ÎÄÏ×·ÖÏí
Pan Jun-Xi, Xia Jin-Jun, Deng Feng-Li et al. Diagnosis of major depressive disorder based on changes in  multiple plasma neurotransmitters: a targeted metabolomics study [J]. Transl Psychiatry, 2018, 8: 130.

Ãâ·ÑÉêÇëGC-MS·Ç°Ð±ê´úл×éѧ

΢ÐÅ

ÔÚÏß
×Éѯ

QQ

µã»÷QQ×Éѯ

·µ»Ø
¶¥²¿

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿